New Research Aims to Optimize Therapy Against Onchocerciasis.

Augustine R Hong, Nicholas O Opoku, Gary J Weil, Eric M Kanza, Michael E Gyasi

Missouri medicine 2022 Jan-Feb

filter terms:

Onchocerciasis is a parasitic disease that is the second most common cause of infectious blindness in the world, affecting 25 million people, mostly in sub-saharan Africa. Mass drug administration (MDA) with ivermectin has been the mainstay of a successful international effort to reduce the burden of vision loss. Despite improvements in infection rates and blindness through MDA with ivermectin, adult worms are not killed or permanently sterilized by this drug and can live for greater than 10 years. Therefore, new treatments for onchocerciasis are critical to accelerating the rate of elimination of this blinding disease. Here we discuss an ongoing study of a new treatment for onchocerciasis. Copyright 2022 by the Missouri State Medical Association.

Citation

Augustine R Hong, Nicholas O Opoku, Gary J Weil, Eric M Kanza, Michael E Gyasi. New Research Aims to Optimize Therapy Against Onchocerciasis. Missouri medicine. 2022 Jan-Feb;119(1):55-59